39 related articles for article (PubMed ID: 1813438)
1. Antibacterial activity of ciprofloxacin administered intravenously in a pharmacodynamic in vitro model.
Esposito S; Jansen A
Int J Clin Pharmacol Res; 1991; 11(4):193-9. PubMed ID: 1813438
[TBL] [Abstract][Full Text] [Related]
2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
3. Overview of Scandinavian in vitro studies with ciprofloxacin.
Forsgren A
Scand J Infect Dis Suppl; 1989; 60():16-22. PubMed ID: 2667106
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model.
Dudley MN; Mandler HD; Gilbert D; Ericson J; Mayer KH; Zinner SH
Am J Med; 1987 Apr; 82(4A):363-8. PubMed ID: 3555061
[TBL] [Abstract][Full Text] [Related]
5. Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model.
Dalhoff A
Infection; 2005 Dec; 33 Suppl 2():44-9. PubMed ID: 16518711
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of in vitro activity of ciprofloxacin and pefloxacin against strains isolated from clinical material].
Kumelj M; Rus A; Music E
Plucne Bolesti; 1989; 41(3-4):193-5. PubMed ID: 2636406
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Kreil VE; Landoni MF
J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
Kayser FH; Novak J
Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
[TBL] [Abstract][Full Text] [Related]
11. Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae.
Garrison MW
J Antimicrob Chemother; 2003 Sep; 52(3):503-6. PubMed ID: 12917240
[TBL] [Abstract][Full Text] [Related]
12. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
Kowalski RP; Karenchak LM; Gordon YJ
Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
[TBL] [Abstract][Full Text] [Related]
15. Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M; Poch F; Quassem C; Kitzes R
Antimicrob Agents Chemother; 1994 Apr; 38(4):837-41. PubMed ID: 8031055
[TBL] [Abstract][Full Text] [Related]
16. Serum inhibitory and bactericidal activity of ciprofloxacin following intravenous administration.
Dudley MN; Mandler HD; Mayer KH; Zinner SH
DICP; 1989 Jun; 23(6):456-60. PubMed ID: 2741478
[TBL] [Abstract][Full Text] [Related]
17. Intraphagocytic killing of gram-positive bacteria by ciprofloxacin.
Pemán J; Cantón E; Hernández MT; Gobernado M
J Antimicrob Chemother; 1994 Dec; 34(6):965-74. PubMed ID: 7730239
[TBL] [Abstract][Full Text] [Related]
18. Questioning dosing regimens of ciprofloxacin.
Bauernfeind A
J Antimicrob Chemother; 1993 May; 31(5):789-98. PubMed ID: 8335507
[No Abstract] [Full Text] [Related]
19. Haemostasis during treatment with ciprofloxacin.
Ziemen M; Shah PM; Breddin K
Infection; 1988; 16 Suppl 1():S65-8. PubMed ID: 3131252
[TBL] [Abstract][Full Text] [Related]
20. Disc sensitivity testing with ciprofloxacin.
Andrews JM; Wise R
J Antimicrob Chemother; 1989 Jan; 23(1):156-8. PubMed ID: 2745250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
